Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Trelagliptin impurity 2 is an impurity associated with Trelagliptin, a DPP-4 inhibitor. This compound serves as an essential reference for the identification and quantification of potential impurities in pharmaceutical formulations. It is particularly relevant for analytical studies focused on the characterization of drug purity and stability in drug development processes. -
Drug Impurity
Oxcarbazepine impurity 1 is a known impurity associated with the anticonvulsant drug Oxcarbazepine. This compound is utilized primarily in drug development and quality control settings, where assessing the presence and concentration of impurities is critical for ensuring compliance with regulatory standards. Research applications include analytical method development and safety evaluation of pharmaceutical formulations containing Oxcarbazepine. -
Drug Impurity
Doxycycline impurity 2 is a structural impurity associated with the antibiotic Doxycycline. Its presence may affect the purity profile of Doxycycline in pharmaceutical formulations. This compound serves as a reference standard for analytical purposes in drug development and quality control, ensuring that the levels of impurities are monitored in accordance with regulatory guidelines. -
Drug Impurity
Rosuvastatin impurity 25 calcium is a chemical impurity associated with Rosuvastatin calcium, a widely used statin for lowering cholesterol levels. It serves a critical role in analytical research, particularly in the evaluation of drug purity and safety. This impurity is essential for quality control and regulatory compliance in pharmaceutical development. -
Drug Impurity
Rosuvastatin impurity 11 is identified as a chemical impurity associated with the pharmaceutical agent Rosuvastatin. This compound serves as a critical reference standard in the assessment of drug purity and quality control during pharmaceutical development. It is utilized in analytical method validation and regulatory submissions, ensuring compliance with safety and efficacy standards in the production of statin-based therapies. -
Drug Impurity
Candesartan impurity 32 is characterized as a drug impurity associated with candesartan synthesis. This compound is important for the quality control and analytical assessments of candesartan formulations. Its identification and quantification are crucial for ensuring the purity and safety of pharmaceutical products containing candesartan. -
Drug Impurity
Trazodone Impurity 5 Hydrochloride is a known impurity associated with the antidepressant Trazodone Hydrochloride. This compound is primarily utilized in pharmaceutical development and quality control studies to assess drug purity and compliance with regulatory standards. Its characterization aids in understanding the stability and safety profile of Trazodone formulations. -
Drug Impurity
Itraconazole impurity 7, also known as Itraconazole impurity B, is a known impurity of the antifungal agent Itraconazole. It serves as a critical substance for the evaluation of drug purity, safety, and efficacy in pharmaceutical research. This compound is utilized in analytical chemistry and quality control processes to ensure the integrity of Itraconazole formulations. -
Drug Impurity
Levomedetomidine is a drug impurity associated with the anesthetic agent dexmedetomidine. It serves as a valuable reference compound in the analysis and characterization of pharmaceutical formulations. Its presence may influence the pharmacological properties and safety profile of dexmedetomidine, making it important for quality control and regulatory compliance in drug development studies. Researchers can utilize levomedetomidine to better understand the implications of drug impurities in pharmacokinetics and efficacy. -
Drug Impurity
Telmisartan impurity 3 is a recognized impurity of the antihypertensive agent telmisartan. Its presence can be relevant in pharmaceutical development and quality control processes. This compound serves as a useful reference standard for analytical methods and ensures the integrity and safety of telmisartan formulations in research applications. -
Drug Impurity
Dexamethasone acetate impurity 1 is a known impurity of Dexamethasone acetate, a synthetic corticosteroid. This compound is primarily utilized in quality control and analytical chemistry to assess the purity of Dexamethasone acetate formulations. It serves as a key reference standard for studies on drug formulation and stability, ensuring compliance with regulatory standards in pharmaceutical research. -
Drug Impurity
Raloxifene impurity 4 is a chemical impurity associated with Raloxifene, a selective estrogen receptor modulator (SERM). It serves as a critical reference standard in the analysis of drug formulation and quality control processes. Researchers can utilize this impurity to assess the purity of Raloxifene in pharmaceutical preparations, ensuring compliance with regulatory standards and enhancing the safety and efficacy of therapeutic applications. -
Drug Impurity
Candesartan impurity 24 is a chemical impurity associated with Candesartan, an angiotensin II receptor antagonist. This compound is primarily utilized in research for the assessment of drug purity and the development of analytical methods for quality control. Its presence in formulations can significantly impact pharmacological efficacy and safety profiles, making it essential for studies focused on drug formulations and stability. -
Drug Impurity
Bupropion impurity 2 is a secondary metabolite associated with Bupropion, a widely used antidepressant and smoking cessation aid. This impurity may influence pharmacokinetic properties and can be utilized in studies assessing the quality and safety of pharmaceutical formulations. Its assessment is crucial for understanding the overall therapeutic profile of Bupropion and ensuring compliance with regulatory standards in drug development. -
Drug Impurity
Sertraline impurity 10 is a chemical impurity associated with the selective serotonin reuptake inhibitor (SSRI) sertraline. This impurity is relevant for analytical and quality control studies in pharmaceutical research, particularly in the assessment of sertraline's purity and stability. Its presence may impact the safety and efficacy profile of sertraline, making it essential for compliance with regulatory standards in drug development. -
Drug Impurity
Tranexamic acid impurity 1 is a chemical impurity associated with Tranexamic acid, a synthetic derivative of lysine that inhibits fibrinolysis through the blockade of plasminogen activation. This compound serves as a critical reference standard for quality control and analytical validation in pharmaceutical development. Its characterization is essential for ensuring the purity and safety of Tranexamic acid formulations used in various medical applications. -
Drug Impurity
Baroxavir impurity 17 is a known impurity of Baroxavir, a drug primarily targeting viral RNA polymerases. This compound serves as an important reference standard in analytical chemistry, facilitating the assessment of purity and quality in Baroxavir formulations. Its characterization is crucial for ensuring compliance with regulatory standards in pharmaceutical research and development. -
Drug Impurity
Lopinavir impurity 7 is a characterized impurity of the antiviral compound Lopinavir, which primarily targets the HIV protease enzyme. This impurity is significant for analytical studies and quality control in pharmaceutical research, ensuring the integrity and safety of Lopinavir formulations. Its presence can influence the pharmacokinetic and pharmacodynamic properties of the parent compound, making it a valuable reference for investigators focused on drug development and formulation optimization. -
Drug Impurity
Fulvestrant impurity 1, also known as Fulvestrant 9-sulfone, is a known impurity of the selective estrogen receptor downregulator fulvestrant. It serves as a useful reference compound in the analysis of drug purity and stability in pharmaceutical formulations. This reagent is applicable in quality control and characterization studies within drug development and regulatory compliance. -
Drug Impurity
Esomeprazole impurity 2 is a known impurity associated with Esomeprazole, which is commonly used as a proton pump inhibitor. This compound is valuable for analytical and quality control purposes in pharmaceutical research, facilitating the assessment of drug purity and stability. Its identification and characterization are essential for ensuring compliance with regulatory standards in drug development and manufacturing. -
Drug Impurity
Aripiprazole impurity 35 is a known impurity associated with the antipsychotic drug Aripiprazole. This compound is primarily studied for its potential effects on the pharmacokinetics and safety profile of the parent drug. Researchers utilize this impurity in analytical studies to assess the purity of Aripiprazole formulations and to understand the implications of drug impurities on therapeutic efficacy and patient safety. -
Drug Impurity
tert-Butyl (6-(4-hydroxyphenoxy)hexyl) carbonate is identified as a drug impurity associated with pharmaceutical formulations. This compound is significant for its potential effects on drug stability and efficacy, making it relevant for quality control and analytical chemistry applications in drug development. Researchers may utilize this reagent to evaluate impurities in synthetic processes or assess compliance with regulatory standards. -
Cefazolin Impurity
Cefazolin Impurity H is a byproduct generated in the synthesis of Cefazolin, a semi-synthetic cephalosporin antibiotic. This impurity can be used as a reference standard in analytical chemistry for the identification and quantification of Cefazolin in pharmaceuticals. It is essential for ensuring the quality and efficacy of cefazolin formulations in research and development. -
Drug Impurity
Prasugrel chloride impurity maleate is a known impurity of Prasugrel chloride maleate, primarily used in pharmaceutical research and quality control applications. Its presence is critical for understanding the purity levels and potential implications for drug safety and efficacy. This compound enables the assessment of drug formulations to ensure compliance with regulatory standards in the development of antiplatelet therapies. -
Drug Impurity
Haloperidol impurity 18 is a known impurity associated with the antipsychotic drug Haloperidol. This compound is relevant for quality control and analytical research applications, as it aids in assessing the purity of Haloperidol formulations. It is essential for researchers investigating drug metabolism and safety profiles, contributing to a better understanding of pharmaceutical quality standards. -
Drug Impurity
Buspirone impurity 11 is a characterized impurity of the anxiolytic agent buspirone. It serves as a key reference standard for quality control and safety assessment in pharmaceutical formulations containing buspirone. This compound is essential for understanding the implications of drug impurities on therapeutic efficacy and patient safety during drug development and regulatory compliance. -
Drug Impurity
Bumetanide impurity 5 is a characterized impurity associated with the diuretic agent Bumetanide. This compound is important for analytical and quality control studies related to the synthesis and purity assessment of Bumetanide. It is utilized in pharmacokinetic research and drug formulation development to ensure compliance with regulatory standards for pharmaceutical products. -
Drug Impurity
Sitagliptin impurity 9 phosphate is a known impurity associated with Sitagliptin phosphate. This compound serves as an important reference standard for the assessment of drug purity and quality control in pharmaceutical formulations. Its presence is critical for the evaluation of Sitagliptin's safety and efficacy in therapeutic applications, particularly in the management of Type 2 diabetes. -
Drug Impurity
Tacrolimus impurity 9 is a known impurity of the immunosuppressant Tacrolimus, primarily affecting its chemical profile. This compound serves as a critical reference standard for analytical methods in the identification and quantification of Tacrolimus-related impurities. Its study is essential for ensuring the quality and safety of Tacrolimus formulations in pharmaceutical research and development. -
Drug Impurity
Citalopram impurity 11 is a known impurity associated with the selective serotonin reuptake inhibitor citalopram. Its presence is relevant in the analysis of pharmaceutical formulations and can serve as a reference standard in purity assessments. This compound is important for ensuring the quality control of citalopram and may facilitate studies on drug metabolism and safety profiles. -
Drug Impurity
Avibactam impurity 53 is a chemical impurity associated with the synthesis of Avibactam, a beta-lactamase inhibitor. This compound is relevant for analytical studies and quality control in drug development and formulation. It assists researchers in understanding and characterizing the purity profile of Avibactam-related compounds, facilitating compliance with regulatory standards in pharmaceutical research. -
Drug Impurity
Ropinirole impurity 2 is a chemical impurity associated with the synthesis of Ropinirole, a dopamine receptor agonist. This compound can be utilized for analytical purposes in the assessment of drug purity and quality control in pharmaceutical research. Its presence is significant for the evaluation of Ropinirole formulations and may impact the overall efficacy and safety profile of the drug. -
Drug Impurity
Tenofovir impurity 8 is a known impurity of Tenofovir, a nucleotide reverse transcriptase inhibitor. This compound may be used for quality control and characterization in pharmaceutical research to ensure the purity and safety of Tenofovir formulations. Its presence is critical for understanding the chemical profile and potential impacts on therapeutic efficacy and safety. -
Drug Impurity
Rosuvastatin TMBA (ZD 4522 TMBA) is a drug impurity associated with the cholesterol-lowering agent rosuvastatin. It is predominantly used in analytical chemistry to assess the purity of pharmaceutical formulations. Researchers utilize this compound to study the degradation pathways and stability of rosuvastatin in various formulations, contributing to quality control and regulatory compliance in drug development. -
Drug Impurity
Dabigatran impurity 14 hydrochloride is a known impurity associated with the anticoagulant drug Dabigatran. This compound is utilized primarily in quality control and validation studies within pharmaceutical development. Its presence can impact the safety and efficacy profiles of Dabigatran, making it essential for research focused on drug formulation and compliance with regulatory standards. -
Drug Impurity
Ketoconazole impurity 17 is a known impurity of the antifungal agent Ketoconazole. This compound is utilized primarily in quality control and analytical research to assess the purity of Ketoconazole formulations. Its presence may have implications for the drug's safety and efficacy, making it critical for pharmaceutical development and regulatory compliance. -
Drug Impurity
Apixaban impurity 18 is a characterized impurity associated with Apixaban, a direct oral anticoagulant that inhibits Factor Xa. This reagent is crucial for quality control and method development in pharmaceutical research, enabling the assessment of purity levels in drug formulations. Its analysis is essential for ensuring compliance with regulatory standards in the development and manufacture of anticoagulant therapies. -
Budesonide Impurity
17-Carboxy Budesonide is a relevant impurity of Budesonide, serving as an important compound for quality control and analytical purposes in pharmaceutical research. Its identification and quantification are crucial in the development and validation of Budesonide formulations. This reagent is essential for studies focused on drug impurities and their potential effects on pharmacokinetics and pharmacodynamics. -
Drug Impurity
Solifenacin impurity 5, also known as Solifenacin impurity G, is a chemical impurity associated with Solifenacin, a muscarinic receptor antagonist. This compound is relevant for analytical and quality control applications in pharmaceutical research. It is essential for studying the purity and stability of Solifenacin formulations, helping researchers ensure compliance with regulatory standards. -
Drug Impurity
Alectinib impurity 1 is a known impurity of the ALK inhibitor Alectinib, which primarily targets anaplastic lymphoma kinase. This impurity is crucial for quality control and analytical purposes in the pharmaceutical development of Alectinib and its formulations. It can also be utilized in studies focused on the structural characterization and stability of drug compounds. -
Drug Impurity
Azithromycin impurity 18 is a known impurity associated with the antibiotic Azithromycin. This compound serves as an important reference standard for quality control and stability testing in pharmaceutical research. Its characterization is essential for ensuring the purity and efficacy of Azithromycin in drug formulations, making it valuable for analytical chemists and researchers studying pharmaceutical compounds. -
Drug Impurity
Atorvastatin impurity 3 is a chemical impurity associated with Atorvastatin, a widely used statin for lowering cholesterol levels. This impurity may serve as a reference standard for quality control in pharmaceutical research and development. It is relevant for studies focused on the analysis of drug purity and stability during formulation processes. -
Drug Impurity
Salbutamol impurity 9 is a recognized impurity associated with Salbutamol, a medication primarily used as a bronchodilator in the management of asthma and chronic obstructive pulmonary disease (COPD). This impurity serves as a reference standard in analytical chemistry and drug quality control, aiding in the identification and quantification of related substances in pharmaceutical formulations. Its role in research supports the assessment of drug purity and the development of robust analytical methods. -
Drug Impurity
Rifaximin impurity 2 is a chemical impurity associated with Rifaximin, a broad-spectrum antibiotic. This compound serves as a reference standard in quality control and analytical testing of Rifaximin formulations. Its characterization is essential for ensuring the integrity and efficacy of drug products during development and manufacturing processes in pharmaceutical research. -
Drug Impurity
Tamsulosin impurity 17 is a chemical impurity associated with the synthesis of Tamsulosin, an alpha-1 adrenergic antagonist. This impurity is significant for analytical chemistry applications, particularly in the characterization and quality control of pharmaceutical formulations containing Tamsulosin. Its presence is crucial in ensuring compliance with regulatory standards and enhancing the understanding of the compound's purity profile in research contexts. -
Netilmicin impurity
Cyclic iodixanol is an impurity associated with iodixanol, a non-ionic radiocontrast agent containing iodine. Its presence can be critical for analytical studies in pharmaceutical development and quality control. Researchers may utilize cyclic iodixanol to investigate the effects of impurities on drug efficacy and safety profiles, particularly in formulations involving iodixanol. -
Drug Impurity
Trazodone impurity 18 is a chemical impurity associated with Trazodone. It serves as a critical reference standard for quality control and analytical testing in pharmaceutical research. Its characterization supports investigations into the metabolic pathways and potential side effects of Trazodone, facilitating a comprehensive understanding of drug safety and efficacy. -
Drug Impurity
Roflumilast impurity 4 is a noted impurity associated with the phosphodiesterase-4 (PDE4) inhibitor Roflumilast. This compound is relevant in the quality control of pharmaceutical formulations, ensuring the purity and safety of the active drug substance. It is utilized in analytical chemistry applications to assess and characterize impurities in drug development processes, particularly in respiratory therapeutics. -
Drug Impurity
Azithromycin impurity 13 is a chemical impurity associated with the antibiotic azithromycin. It serves as a critical component in quality control and analytical chemistry, facilitating the assessment of the compound's purity and stability. This impurity may impact the pharmacological profile of azithromycin and is essential for researchers focusing on drug metabolism and formulation studies. -
Drug Impurity
Buspirone impurity 8 is a known impurity of the anxiolytic compound Buspirone. This reagent serves as a critical tool for quality control and analytical studies in pharmaceutical research and development. Its characterization and quantification are essential for ensuring the purity and safety of Buspirone formulations. Researchers can utilize this impurity to assess the efficacy and stability of related pharmaceutical compounds.
